Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Compound 4 is a promising treatment for hair loss with low toxicity.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Testosterone in human pancreas cells boosts insulin production.

Testosterone in our bodies helps increase insulin secretion from the pancreas.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Male pattern baldness may be linked to prostate cancer risk.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Certain compounds found in edible mushrooms may help treat hair loss.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.